Efficacy of Sofosbuvir-Daclatasvir in Treatment of Chronic Hepatitis C Virus Infection

Assessment of Patient Compliance during treatment of chronic hepatitis C infection using Sofosbuvir and Daclatasvir with or without Ribavirin.

Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience

EFFICACY OF SOFOSBUVIR, DACLAVIR AND RIBAVIRIN IN TREATMENT OF HCV INFECTION WITH DIFFERENT STAGES OF LIVER DISEASE

The effect of the polymorphism in IL-28B gene on the treatment response of a combined therapy by sofosbuvir and daclatasvir with and without ribavirin in HCV Egyptian patients

Predictors of Sustained Virological Response in Chronic Hepatitis C Patients Treated with Current Direct Acting Antiviral Drugs

Efficacy and Adverse Effects of Sofosbuvir-Based Therapies (Double and Triple Regimens) in Chronic HCV Patients

Evaluation of efficacy and safety of daclatasvir and sofosbuvir in treatment of chronic hepatitis C infection

Response to Hepatitis B Vaccine in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals

Efficacy and Safety of Omibtasvir, Paritaprevir and Ritonavir Combination with Ribavirin for Treatment of Chronic Hepatitis C Patients